GSPT1 and leukemia: Therefore, we aimed to create a humanized mouse Crbn for the study of GSPT1 degraders and develop an in vivo model sensitive to both CC-885 and CC-90009 to study the efficacy and toxicity of these molecules for the treatment of leukemia.